A new study by researchers at the Icahn School of Medicine at Mount Sinai has unraveled the intricate molecular interplay between systemic processes within the blood and localized processes within the airways of individuals with asthma.
This pioneering research opens doors to potential novel treatments targeting specific molecules, with the aim of providing more effective relief for asthma patients. The research findings were published today in Genome Medicine.